KOSDAQ large cap
Chabiotech
A biotech spanning stem-cell therapeutics, cell banking and cord-blood and medical services. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
085660.KQ Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-07-10'21-8%'22-15.3%'23+29.1%'24-37.6%'25+91.7%YTD-53.3%
Money in ▸·
Chabiotech
▸ Money out·
Financials & Segments
- Segments · Cell therapy and stem cells · Medical (hospitals) and healthcare · Cord blood banking
Revenue from
No refined links yet.
Pays to
No refined links yet.